AnalizaDx, GHMI Partner to Bring Cancer Dx to Africa, the Caribbean | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics firm AnalizaDx and informatics company Global Health Management Informatics today announced a licensing agreement to offer AnalizaDx's tests in Africa and the Caribbean.

GHMI will start offering the tests in Nigeria and South Africa. Through a network of hospitals and clinical laboratories with which it collaborates, the Houston-based firm will begin offering AnalizaDx's PSA/SIA, a prostate cancer test, which can differentiate the cancer from other benign conditions using a blood sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.